NCT03174067View on ClinicalTrials.gov

Buprenorphine in the Emergency Department

PHASE4CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

April 30, 2016

Study Completion Date

November 30, 2016

Conditions
Opioid WithdrawalOpioid-use Disorder
Interventions
DRUG

Buprenorphine

The participant receives buprenorphine

DRUG

Clonidine

The participant receives clonidine

All Listed Sponsors
lead

St. Joseph's Health Centre Toronto

OTHER

NCT03174067 - Buprenorphine in the Emergency Department | Biotech Hunter | Biotech Hunter